Matches in Nanopublications for { ?s ?p "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP610524.RADQLfjAap8JsQRj-Io-7ZoBLwgB6oQTI1c_W7UBBUd5I130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610524.RADQLfjAap8JsQRj-Io-7ZoBLwgB6oQTI1c_W7UBBUd5I130_provenance.
- NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921174.RAh4mTI-2-tyHBu8q4uvG5piFi8JYLxkMyprLjvjquYto130_provenance.
- NP842371.RAbQ2GM_9SXxYgyr8PgSd2eMDsCtn1ZEN0h_KiewK5mLg130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842371.RAbQ2GM_9SXxYgyr8PgSd2eMDsCtn1ZEN0h_KiewK5mLg130_provenance.
- assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP361381.RAFOIEcjkEjG_RYMiw0gJMdpRLVlteE01aylxuOd2i0j0130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361381.RAFOIEcjkEjG_RYMiw0gJMdpRLVlteE01aylxuOd2i0j0130_provenance.
- NP341108.RAVEvTkk_ZknX4FS2U75S6STPitO-U0JluxOx1fzDc--E130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341108.RAVEvTkk_ZknX4FS2U75S6STPitO-U0JluxOx1fzDc--E130_provenance.
- NP703070.RADs7Mv58pluK4d-cWx_OGGyCiKoM2bpGfTpJifazxnZg130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703070.RADs7Mv58pluK4d-cWx_OGGyCiKoM2bpGfTpJifazxnZg130_provenance.
- NP341080.RAgQB7l_8Y3s_yBGJ35v0gWHDc7p2jFcav9Dmy6aI2Ap0130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341080.RAgQB7l_8Y3s_yBGJ35v0gWHDc7p2jFcav9Dmy6aI2Ap0130_provenance.
- NP341355.RAqCzlP8MD97vCqOsF1_vrjXTXlWMfSrNeu3_mXf6pTlw130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341355.RAqCzlP8MD97vCqOsF1_vrjXTXlWMfSrNeu3_mXf6pTlw130_provenance.
- NP703066.RAHfjfHYN56wTTPAFmdglxuVAdl9FXk-bzS4tkI_Gua5U130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703066.RAHfjfHYN56wTTPAFmdglxuVAdl9FXk-bzS4tkI_Gua5U130_provenance.
- NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_provenance.